Hotchkis & Wiley Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.95M | Sell |
|
|||||
|
2023
Q3 | $8.26M | Buy |
|
|||||
|
2023
Q2 | $8.34M | Buy |
|
|||||
|
2023
Q1 | $9.78M | Buy |
|
|||||
|
2022
Q4 | $9.89M | Buy |
|
|||||
|
2022
Q3 | $7.4M | Buy |
|
|||||
|
2022
Q2 | $8.45M | Buy |
|
|||||
|
2022
Q1 | $9.99M | Buy |
|
|||||
|
2021
Q4 | $10M | Buy |
|
|||||
|
2021
Q3 | $7.57M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.12M | Sell |
|
|||||
|
2018
Q3 | $3.13M | Buy |
|
|||||
|
2018
Q2 | $1.78M | Buy |
|
|||||
|
2018
Q1 | $1.03M | Hold |
|
|||||
|
2017
Q4 | $906K | Buy |
|